Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
September, 2026
September 2026
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
AUREA – No Added Benefit of Short-Term OAC Post-TAVI in Patients Without OAC Indication
Davide Capodanno/X
Jul 8, 2025, 07:56

AUREA – No Added Benefit of Short-Term OAC Post-TAVI in Patients Without OAC Indication

Davide Capodanno, Professor of Cardiology at University of Catania, Italy has posted on X:

“In the randomized, open-label AUREA trial, an OAC strategy for 3 months post-TAVI did not show any benefit over an antiplatelet strategy in preventing cerebral microembolism in patients without an indication for OAC. Patients treated with DAPT showed a lower mean volume of brain damage on DW-MRI during the 90 days following TAVI compared to those treated with acenocoumarol.”

AUREA - No Added Benefit of Short-Term OAC Post-TAVI in Patients Without OAC Indication

You can read the Full Article here.

Explore more on Hemostasis Today.

antiplatelet strategy AUREA trial Davide Capodanno Direct oral anticoagulants (DOACs) Hematology Hemostasis Hemostasis Today thrombosis
NewsFeed